Business
SINTX Technologies Provides End of Year 2021 Business Update
SALT LAKE CITY, Dec. 08, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment
About this update from Sintx Technologies, Inc.
[{"type":"text","content":"SALT LAKE CITY, Dec. 08, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, shared an end of the year 2021 business update including details from its biomedical, antipathogenic, and industrial business segments: Biomedical: Beginning in November 2021, SINTX successfully launched joint research efforts for the recently awarded National Institute of Health (NIH) Small Business Technology Transfer (STTR) grant for 3D-printed silicon nitride PEEK composite spinal implants. The goal of the nine-month collaboration with Drexel University, Thomas Jefferson University, and the University of Pennsylvania School of Veterinary Medicine is to combine the familiar fit and feel of PEEK with the antibacterial and osseointegrative properties of silicon nitride to create a new generation of differentiated spinal implants for prospective partners. Initial efforts have been focused on determining printer parameters and characterizing antibacterial properties for the composite material. The 3D printer to be used in this study was purchased by SINTX in 2021. SINTX has also submitted several other grant applications such as an NIH grant for 3D printed craniomaxillofacial (CMF) devices as well as a Department of Defense (DoD) grant proposal for the development of SINTX coating technologies to reduce the infection burden associated with high-risk implantable device applications. The company plans to announce further details once the outcome of the grant submissions is known. SINTX has successfully completed proof-of-concept experiments to create a composite coating that integrates silicon nitride powder into Oxford Performance Materials, Inc. (OPM) proprietary polymer. Ongoing collaborative development is now focused on optimizing the coating’s adhesion and antimicrobial properties. The Company is continuing to develop new applications and manufacturing technologies in medical devices, with a desire to deliver the osteogenic and antipathogenic benefits of silicon nitride to new areas of the human body. SINTX is leveraging the long-term successful outcomes with silicon nitride spinal implants to find interest in silicon nitride from medical device manufacturers – interest in monolithic silicon nitride, composites of silicon nitride and poly...